BOSTON (PRWEB) MARCH 19, 2020 NanoFUSE Biologics, LLC, the only biologics company with a bioactive glass FDA-cleared to be combined with DBM, announced it has chosen Jake Lubinski, the current President of NanoFUSE Biologics, LLC and President of Commercialization and Acquisition of parent company KICVentures, LLC, as its new CEO effective March 16th 2019. In January …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone